Skip Navigation

Cardiovascular Research 2000 45(1):243-244; doi:10.1016/S0008-6363(99)00337-5
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Linck, B.
Right arrow Articles by Schmitz, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Linck, B.
Right arrow Articles by Schmitz, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Messenger RNA expression and immunological quantification of phospholamban and SR-Ca2+-ATPase in failing and nonfailing human hearts

Bettina Linck* and Wilhelm Schmitz

Institüt für Pharmacologie und Toxikologie, Westfalische Wilhelms-Universität, Domagkstr 12, 48129 Münster, Germany

* Corresponding author. Tel.: +49-251-83-55510; fax: +49-251-83-55501

KEYWORDS Calcium (cellular); Genetic code; Heart failure; SR (function); Ventricular function

The first 10% of the full text of this article appears below.

In the past, there was good evidence that the β-adrenoceptor/adenylycyclase signaling pathway leads to a defective production of cAMP and hence to a reduced contractility in human end-stage heart failure [1,2]. But when we . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?